Planting
Elymus nutans
artificial grassland to replace degraded
Artemisia baimaensis
grassland on the Qinghai Tibetan plateau (QTP) can effectively alleviate local grass-livestock imbalance. However, it is unknown whether the allelopathy of natural grassland plant
A. baimaensis
on
E. nutans
affects grassland establishment. Accordingly, we examined the effects of varying concentrations of aqueous extracts of
A. baimaensis
litter on the seed germination and early seedling growth of
E. nutans
, and the effects of
A. baimaensis
volatile organic compounds (VOCs) on the growth parameters and physiological characteristics of
E. nutans
. The results indicate that the aqueous extract inhibited the force, percentage, and index of germination of
E. nutans
and affected early seedling growth, particularly at high concentrations. Further, the VOCs significantly reduced the aboveground and root biomass of
E. nutans
and increased malondialdehyde concentrations. Additionally, these VOCs altered the antioxidant enzyme activities and increased the superoxide dismutase, peroxidase, ascorbic acid peroxidase, soluble sugar, and proline content but significantly decreased glutathione reductase levels. Our results indicate that the allelopathy of
A. baimaensis
significantly inhibited the germination and seedling growth of
E. nutans
. Thus, the leaching of
A. baimaensis
may produce allelochemicals in the soil that inhibit the germination of
E. nutans
seeds. Moreover, the VOCs of
A. baimaensis
may disrupt the growth process, resulting in a decrease in biomass and a disruption of the physiological metabolism of seedlings under field conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.